509 results
Page 13 of 26
8-K
EX-99.1
99g85a0z o7guxq
8 Aug 11
Ligand Pharmaceuticals Announces Second Quarter Results
12:00am
8-K
EX-99.1
ze7ia7
26 Jul 11
Ligand Partner GlaxoSmithKline Receives Positive Data from Promacta® PIII
12:00am
8-K
EX-99.1
cy72k4jiq2yih6is9s
22 Jun 11
Product has Potential to Offer Important Advantages Over Current IV Melphalan
12:00am
8-K
EX-99.1
ha3qh6
20 Jun 11
Rob McKay, Sr. Dir. Business Development
12:00am
8-K
EX-99.1
3907a0b5pc1
10 May 11
Ligand Pharmaceuticals Reports First Quarter Results
12:00am
8-K
EX-99.1
6ats5dvcbeive3q
18 Apr 11
Ligand Names Matthew W. Foehr Chief Operating Officer
12:00am
8-K/A
EX-99.2
8aowb2i8x8 3a78
12 Apr 11
Financial Statements and Report of Independent Certified Public Accountants
12:00am
8-K/A
EX-99.2
jmpj8c94cd
11 Apr 11
Financial Statements and Report of Independent Certified Public Accountants
12:00am
8-K
EX-10.1
nuxaomdi8zity
4 Apr 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
n2ofkqi2bi5x
15 Feb 11
Ligand Announces Fourth Quarter and Full Year 2010 Consolidated Financial Results
12:00am
8-K
EX-99.1
l6a3li
9 Feb 11
Ligand Appoints John L. LaMattina to Board of Directors
12:00am
8-K
EX-99.1
ey6 u337ock3z0
31 Jan 11
Ligand Forms Strategic Drug Development Alliance with Chiva Pharmaceuticals
12:00am
8-K
EX-10.1
okuxri 7bb
26 Jan 11
Entry into a Material Definitive Agreement
12:00am